Clinical Trial Update: The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating pucotenlimab in combination with TP chemotherapy for locally advanced head and neck squamous cell carcinoma; currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Head and Neck

Drugs mentioned

• Pucotenlimab

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: NOT_YET_RECRUITING